SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Clinical trial NCT00299897 · UNKNOWN

Trial details

NCT number: NCT00299897
Sponsor: Samaritan Pharmaceuticals, Inc
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

HIV Infections Human Immunodeficiency Virus

Start date: 2006-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.